BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10653428)

  • 1. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation.
    Dori D; Beiran I; Gelfand Y; Lanir N; Scharf J; Miller B; Brenner B
    Am J Ophthalmol; 2000 Jan; 129(1):106-8. PubMed ID: 10653428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of nonarteritic anterior ischemic optic neuropathy associated with coexisting primary antiphospholipid syndrome and Factor V Leiden mutation.
    Srinivasan S; Fern A; Watson WH; McColl MD
    Am J Ophthalmol; 2001 May; 131(5):671-3. PubMed ID: 11336954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consecutive central retinal artery and vein occlusions in primary antiphospholipid syndrome.
    Levy J; Baumgarten A; Rosenthal G; Rabinowitz R; Lifshitz T
    Retina; 2002 Dec; 22(6):784-6. PubMed ID: 12476107
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myocardial infarction as an initial symptom of antiphospholipid syndrome, factor V Leiden mutation, and hyperhomocysteinemia].
    Dropiński J; Wegrzyn W; Szczeklik W; Krzanowski M
    Pol Arch Med Wewn; 2004 Jan; 111(1):63-7. PubMed ID: 15088423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinal artery occlusion and anterior ischemic optic neuropathy associated with factor V Leiden mutation: A case report].
    Elleuch IE; Sayadi S; Rahali N; Dridi T; Zbiba W
    J Fr Ophtalmol; 2020 Apr; 43(4):294-297. PubMed ID: 32107025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral cilioretinal artery occlusion in antiphospholipid syndrome.
    Carrero JL; Sanjurjo FJ
    Retina; 2006 Jan; 26(1):104-6. PubMed ID: 16395148
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor V Leiden mutation and antiphospholipid syndrome: risk factors for atherosclerotic and arterial thromboembolic disease.
    Thakor AS; Shah D; Miller F; Gaunt ME
    J Vasc Interv Radiol; 2009 Aug; 20(8):1097-8. PubMed ID: 19574060
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant therapy after retinal vein occlusion in patients with protein S deficiency (Protein S deficiency with homozygous factor V Leiden mutation in central retinal vein occlusion. Vol. 42[4]).
    Rehak M; Krcova V; Slavik L; Müller M; Rehak J
    Can J Ophthalmol; 2007 Dec; 42(6):875; author reply 876. PubMed ID: 18059510
    [No Abstract]   [Full Text] [Related]  

  • 9. Bilateral occlusive retinal vasculitis in a patient with primary antiphospholipid antibody syndrome.
    Turaka K; Bryan JS; Kwong HM; Ziemianski MC
    Can J Ophthalmol; 2012 Dec; 47(6):e60-1. PubMed ID: 23217524
    [No Abstract]   [Full Text] [Related]  

  • 10. Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor.
    Dhar-Munshi S; Ayliffe WH; Jayne D
    Arch Ophthalmol; 1999 Jul; 117(7):971-3. PubMed ID: 10408469
    [No Abstract]   [Full Text] [Related]  

  • 11. [Retinal vascular occlusion and primary antiphospholipid syndrome. Report of 2 cases].
    Vielpeau I; Le Hello C; Legris A; Salsou E; Lecoq PJ
    J Fr Ophtalmol; 2001 Nov; 24(9):955-60. PubMed ID: 11912840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent central retinal vein occlusion in a young thrombophilic patient with factor V Leiden mutation.
    Incorvaia C; Bandello F; Parmeggiani F; D'Angelo S; Costagliola C; Sebastiani A
    Eur J Ophthalmol; 2002; 12(2):131-4. PubMed ID: 12022286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations.
    Talmon T; Scharf J; Mayer E; Lanir N; Miller B; Brenner B
    Am J Ophthalmol; 1997 Nov; 124(5):689-91. PubMed ID: 9372726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombophilia factors as inducers of retinal vascular occlusion].
    Lerche RC; Wilhelm C; Eifrig B; Richard G
    Ophthalmologe; 2001 Jun; 98(6):529-34. PubMed ID: 11450475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment.
    Au A; O'Day J
    Clin Exp Ophthalmol; 2004 Feb; 32(1):87-100. PubMed ID: 14746601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined retinal artery and vein occlusion in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
    Durukan AH; Akar Y; Bayraktar MZ; Dinc A; Sahin OF
    Can J Ophthalmol; 2005 Feb; 40(1):87-9. PubMed ID: 15825539
    [No Abstract]   [Full Text] [Related]  

  • 17. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS.
    Demirci FY; Küçükkaya R; Akarçay K; Kir N; Atamer T; Demirci H; Ongör E
    Int Ophthalmol; 1998; 22(6):323-9. PubMed ID: 10937845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SEQUENTIAL CENTRAL RETINAL VEIN AND OPHTHALMIC ARTERY OCCLUSIONS IN A PEDIATRIC CASE OF PRIMARY ANTIPHOSPHOLIPID SYNDROME.
    Gelman R; Tsang SH
    Retin Cases Brief Rep; 2016; 10(1):58-62. PubMed ID: 26110520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibody syndrome.
    Yang P; Kruh JN; Foster CS
    Curr Opin Ophthalmol; 2012 Nov; 23(6):528-32. PubMed ID: 23042148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of factor V Leiden and primary antiphospholipid syndrome: a patient with recurrent myocardial infarctions and thrombocytopenia.
    Schütt M; Klüter H; Wiedemann GJ; Richardt G
    Z Kardiol; 2000 Dec; 89(12):1067-71. PubMed ID: 11201021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.